The complexity of the ERK/MAP kinase pathway and the treatment of melanoma skin cancer
The central role played by the ERK/MAPK pathway downstream of RAS in human neoplasias is best exemplified in the context of melanoma skin cancer. Signalling through the MAPK pathway is crucial for the proliferation of melanocytes, the healthy pigment cells that give rise to melanoma. However, hyper-...
Main Authors: | Claudia eWellbrock, Imanol eArozarena |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fcell.2016.00033/full |
Similar Items
-
Targeting the ERK Signaling Pathway in Melanoma
by: Paola Savoia, et al.
Published: (2019-03-01) -
Specifically targeting ERK1 or ERK2 kills Melanoma cells
by: Qin Jianzhong, et al.
Published: (2012-01-01) -
Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
by: Yufan Tan, et al.
Published: (2021-06-01) -
Molecular background of skin melanoma development and progression: therapeutic implications
by: Magdalena Olbryt
Published: (2019-05-01) -
Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines
by: Kim Ji Eun, et al.
Published: (2012-04-01)